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Summary
 
CD8
 
1
 
 T lymphocytes confer significant but ultimately insufficient protection against HIV in-
fection. Here we report that activated neonatal CD8
 
1
 
 T cells can be productively infected in
vitro by macrophage-tropic (M-tropic) HIV-1 isolates, which are responsible for disease
transmission, whereas they are resistant to T cell–tropic (T-tropic) HIV strains. Physiological
activation of CD8-
 
a
 
/
 
b
 
1
 
 CD4
 
2
 
 T cell receptor–
 
a
 
/
 
b
 
1
 
 neonatal T cells, including activation by
allogeneic dendritic cells, induces the accumulation of CD4 messenger RNA and the expres-
sion of CD4 Ag on the cell surface. The large majority of anti-CD3/B7.1–activated cord blood
CD8
 
1
 
 T cells coexpress CD4, the primary HIV receptor, as well as CCR5 and CXCR4, the
coreceptors used by M- and T-tropic HIV-1 strains, respectively, to enter target cells. These
findings are relevant to the rapid progression of neonatal HIV infection. Infection of primary
HIV-specific CD8
 
1
 
 T cells may compromise their survival and thus significantly contribute to
the failure of the immune system to control the infection. Furthermore, these results indicate a
previously unsuspected level of plasticity in the neonatal immune system in the regulation of
CD4 expression by costimulation.
 
C
 
D8
 
1
 
 T lymphocytes play a protective role during the
acute and chronic phases of HIV-1 infection. In addi-
tion to eliminating productively infected cells through their
cytotoxic activity, CD8
 
1
 
 T cells also release soluble factors
(macrophage inflammatory protein [MIP]-1
 
a
 
, MIP-1
 
b
 
,
regulated on activation, normal T cell expressed and se-
creted [RANTES], IL-16, and other unidentified factors)
that inhibit cell entry and intracellular replication of HIV-1
(for review see references 1 and 2). In most adult patients,
HIV triggers a rapid and strong cytotoxic CD8
 
1
 
 T cell re-
sponse that appears to limit viral replication during the ini-
tial acute phase of the infection (3, 4). The efficiency of the
initial CD8
 
1
 
 T cell response, as reflected by the viral bur-
den at the end of the acute episode, is thought to deter-
mine the rate of disease progression to AIDS (5, 6). In the
majority of adults, the viral load declines rapidly after pri-
mary HIV infection and the disease progresses slowly, with
a median clinical latent phase of about 9 yr. In contrast, the
evolution of neonatal HIV infection, resulting from mater-
nal–infant transmission, is often much faster, with the high-
est incidence of pediatric AIDS occurring during the first
year of life (7). In perinatally infected infants, plasma HIV
levels peak at 1 to 2 mo of age and decline only very slowly
during the first 2 yr of life (8). This may be related to an in-
sufficient neonatal HIV-specific CD8
 
1
 
 T cell response
characterized by a smaller amplitude and a more restricted
TCR repertoire than in adults (9). Here we provide a
mechanism that may contribute to the inefficient response
of neonatal CD8
 
1
 
 T cells by showing that these cells can be
productively infected in vitro by HIV.
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HIV Infection of CD8
 
1
 
 T Cells
 
Materials and Methods
 
Lymphocyte Preparation and Culture Conditions.
 
CD8
 
1
 
 and CD4
 
1
 
T cell subsets were isolated from heparinized umbilical cord
blood as described (10). In brief, mononuclear cells obtained by
centrifugation on Ficoll-Metrizoate gradients were treated with
 
l
 
-leucine methyl ester to remove monocytes and NK cells; en-
riched T cells were isolated by treating cells forming rosette with
SRBCs by means of Lympho-Kwik T (One Lambda, Can-
ogalark, CA). CD8
 
1
 
 T cells were positively selected with Dyna-
beads M-450 CD8 (Dynal, Great Neck, NY) and further de-
pleted of CD4
 
1
 
 cells with Dynabeads M-450 CD4; CD4
 
1
 
 T cells
were obtained by treating enriched T cells with Lympho-Kwik T
helper (One Lambda). Neonatal T cell subsets were 
 
.
 
98% CD3
 
1
 
and 
 
,
 
1% CD14, CD20, CD56, or CD16 positive, respectively;
the CD8
 
1
 
 subset was 
 
.
 
95% TCR-
 
a
 
/
 
b
 
1
 
 CD8-
 
a
 
/
 
b
 
1
 
, 
 
.
 
99%
CD45RA
 
1
 
/RO
 
2
 
, and contained no detectable CD4 or CD29
positive cells. T cells were submitted to one or two cycles of acti-
vation and IL-2 expansion as described (11). At each cycle, T
cells were activated with anti-CD3 mAb (UCHT-1, 200 ng/ml;
a gift from P. Beverley, University College and Middlesex School
of Medicine, London, UK) and irradiated CD32, B7.1 trans-
fected L cells for 3 d, and cells were then washed twice and ex-
panded in fresh medium supplemented with 50 IU/ml of IL-2 for
4 d. T cells were then washed and either stored in liquid nitro-
gen, until use for HIV infection, or subjected to another cycle of
activation/expansion.
In some experiments, CD8
 
1
 
 T cells (5 
 
3
 
 10
 
5
 
 cells/ml) were
stimulated with irradiated allogeneic dendritic cells (5 
 
3
 
 10
 
4
 
cells/ml) in the presence of IL-2 (50 IU/ml). Dendritic cells were
derived from adult blood monocytes cultured for 9 d with IL-4,
GM-CSF, and TNF-
 
a
 
 exactly as described (12).
 
Flow Cytometry.
 
One- or two-color flow cytometric analysis
was performed on a FACSort
 
Ò
 
 (Becton Dickinson, Montreal,
Canada) according to standard procedures. The following FITC-
or PE-labeled mAbs or isotype-matched mouse Ig were pur-
chased from Becton Dickinson: anti–CD8-
 
a
 
 (Leu 2a), anti-CD4
(Leu 3a), anti-CD3, anti-CD20, anti-CD14, anti-CD56, and anti-
CD16. CD4 was also stained with OKT4 (American Type Culture
Collection, Rockville, MD); mAb to CD8-
 
a
 
/
 
b
 
 heterodimer
(2ST8) was given by E. Reinherz (Harvard Medical School, Bos-
ton, MA); the anti-CXCR4/fusin mAb (12G5) has been de-
scribed (13).
 
Reverse Transcriptase PCR.
 
Total cellular RNA was extracted
from resting or activated cord blood CD4
 
1
 
 or CD8
 
1
 
 T cells us-
ing RNA ease Total RNA Kit (Qiagen, Chasworth, CA) and pre-
treated with 10 U/ml RNAse-free DNAse (GIBCO BRL, Gaith-
ersburg, MD) before amplification. Synthesis of cDNA and ensu-
ing PCR amplification were performed using Titan
 
TM
 
 reverse
transcriptase (RT)-PCR kit (Boehringer Mannheim, Indianapolis,
IN) according to the supplier’s instruction manual. PCR products
were separated on a 1% agarose gel and stained with ethidium
bromide. Chinese hamster ovary cell RNA served as negative con-
trol for CD4, CXCR4, and CCR5 genes; glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH) was amplified to confirm equal
efficiency of amplification of each RNA. No PCR product was
detected in control amplification containing no added RNA, Taq,
or RT DNA polymerase. Primers for amplification were as follows:
CXCR4: 5
 
9
 
-AGAATTCAACCAGCGGTTACCATGGAGGGG-
ATC, 5
 
9
 
-AGAATTCGTCTTTTACATCTGTGTTAGCTG-
GAG; CCR5: 5
 
9
 
-TCGATCCGGTGGAACAAGATGGATTAT-
CAAG, 5
 
9
 
-TCGGATCCAAGCCATGTGCACAACTCTGA-
CTG; and CD4: 5
 
9
 
-GCAGTGGCGAGCTGTGGT, 5
 
9
 
-GGG-
TCCCCACACCTCACAGG.
 
HIV Infection and Quantitative Gag PCR.
 
Either freshly acti-
vated or cryopreserved neonatal CD4
 
1
 
 and CD8
 
1
 
 cells were in-
fected with HIV-1
 
US-1
 
 or HIV-1
 
NL4-3
 
 as previously described (14,
15). In brief, for each infection 5 
 
3
 
 10
 
6
 
 cells were centrifuged,
washed, and resuspended in 400 
 
m
 
l of media containing 1–3 x 10
 
4
 
tissue culture and infectious dose (TCID)
 
50
 
 of HIV-1. The cells
were incubated at 37
 
8
 
C for 2 h, washed three times to remove
excess virus, and resuspended in 50% conditioned media at 10
 
6
 
/ml.
At 
 
t
 
 
 
5
 
 0, 2, 72, and 144 h after infection, 1,000,000 cells were
pelleted and frozen at 
 
2
 
70
 
8
 
C. The cell pellets were lysed, ampli-
fied by PCR using HIV gag-specific primers, and the amplified
sequences were detected by hybridization to a radiolabeled oligo-
nucleotide specific for internal gag sequences. The hybridized
products were separated by gel electrophoresis and exposed to a
PhosphorImager screen for 1 h. To ensure that the reactions were
performed within the linear range of the assay, log increments
HIV gag plasmid standards were amplified at the same time. To
show that equivalent levels of input DNA were present in each
PCR reaction, human 
 
b
 
-globulin sequences were PCR amplified
as described (15).
 
Intracellular HIV Gag-pol Staining.
 
After washes 1–2 
 
3
 
 10
 
6
 
cells were stained with optimized concentrations of cell surface
marker antibodies for 1 h at 4
 
8
 
C. The cells were washed twice
with sterile PBS, pH 7.4, and fixed in 100 
 
m
 
l of PermeaFix
(Ortho Diagnostics, Raritan, NJ) for at least 1 h at room temper-
ature. Cells were washed in sterile PBS, pH 7.4, pelleted by cen-
trifugation, and then washed again in 2
 
3
 
 standard saline citrate
(SSC). After centrifugation, the cell pellet was resuspended in hy-
bridization solution (2
 
3
 
 SSC, 30% formamide, sonicated salmon
sperm, yeast transfer RNA) containing 500 ng of 5-carboxy-fluo-
rescein double-end–labeled, gag-pol–specific oligonucleotide probes
or gag-pol sense oligonucleotides as a negative control probe
cocktail (16). The intracellular hybridization was performed at
42
 
8
 
C for 1 h followed by successive washes in 2
 
3
 
 SSC, 0.5% Tri-
ton X-100, and 1
 
3
 
 SSC, 0.5% Triton X-100 at 42
 
8
 
C. The cells
were resuspended for analysis in PBS, pH 8.3, and analyzed on a
flow cytometer (Epic XL; Coulter, Miami, FL).
 
Results and Discussion
 
Highly purified umbilical cord blood CD8
 
1
 
 T cells
(
 
.
 
98% CD3
 
1
 
, 
 
.
 
95% TCR-
 
a
 
/
 
b
 
1
 
, CD8-
 
a
 
/
 
b
 
1
 
, no detect-
able CD41 cells) and CD41 T cells (.98% CD31
CD4bright, no detectable CD81 cells) were activated with
anti-CD3 mAb cross-linked on CD32 and B7.1 transfected
L cells, expanded in IL-2–supplemented medium, and then
infected with the macrophage-tropic HIVUS-1 or with the
T cell–tropic (T-tropic) HIVNL4-3 virus; HIV replication
was evaluated at days 3 and 6 after infection by quantitative
PCR analysis of gag DNA accumulation. Both CD81 and
CD41 T cell subsets supported significant replication of the
macrophage tropic (M-tropic), but not the T-tropic, strain
of HIV (Fig. 1), although the initial infection was slower in
CD81 than in CD41 T cells, as judged from the day 3 val-
ues. That HIV infected CD81 T cells, and not contaminat-
ing CD41 cells was supported by 3 lines of evidence. First,
neonatal CD81 T cells were directly shown to contain in-
tracellular HIV. After infection with HIVUS-1 for 6 d,
CD81 T cells were surface stained for CD8 expression and
stained intracellularly for HIV gag and pol RNA sequences.1141 Yang et al. Brief Definitive Report
Fig. 2 shows that only CD81 T cells contained HIV-1 se-
quences. In addition, to confirm that a spreading infection
was occurring in the neonatal CD81 T cells, samples were
collected on both days 3 and 6 after infection and analyzed.
At day 3, 3.4% of the cells were double positive for CD8
and HIV RNA, and by day 6 the number grew to 12.3%,
which is consistent with a productive infection (data not
shown). Second, CD81 T cell cultures did not contain de-
tectable CD4 single positive cells at day 6 after infection
(data not shown). Third, CD4 Ag and CD4 messenger
RNA (mRNA) were undetectable in freshly prepared
CD81 T cells, as assessed by flow cytometry and RT-PCR
analysis respectively (Fig. 3, A and B). Thus, activated neo-
natal CD81 T cells can be productively infected by primary
M-tropic HIV isolates, responsible for disease transmission,
but not by T-tropic HIV. The apparent resistance of neo-
natal CD41 and CD81 T cell subsets to T-tropic HIV
could be related to the recent finding that anti-CD3/B7–
activated naive CD41 T cells isolated from adult blood are
also resistant to T-tropic HIV, as a result of postentry block
in viral replication (17–20).
To be susceptible to HIV infection, a cell must express
CD4, the primary HIV receptor, together with either
CCR5 (the coreceptor for M-tropic strains), or CXCR-4/
fusin (the coreceptor for T-tropic strains) (for review see
reference 21). According to this paradigm, activated neona-
tal CD81 T cells should express CD4 together with at least
CCR5. Indeed, we found that neonatal single positive
CD81 T cells started to express low to moderate levels of
CD4 within 24 h after anti-CD3/B7.1 activation (Fig. 3
A); CD4 expression reached a plateau at 72 h (60 to .90%
double positive cells, n 5 24) and remained stable for at
least 2 wk (the duration of the present experiments). Flow
cytometric analysis of anti-CD3/B7.1–stimulated CD81 T
cells stained with anti-CD4 revealed a unimodal histogram,
suggesting that the ability to coexpress CD4 is a common
property of most, if not the entire, neonatal CD81 T cell
population (Fig. 3 C). Quantitatively, CD4 was expressed
at significantly lower levels on activated CD81 T cells than
on CD4 single positive T cells (Fig. 3 C). RT-PCR analy-
sis revealed that CD4 mRNA was undetectable in freshly
isolated CD81 T cells, but clearly induced after anti-CD3/
B7.1 stimulation, suggesting transcriptional activation of
the CD4 gene (Fig. 3 B). In experiments designed to deter-
mine the minimal requirements for CD4 expression on
neonatal CD81 T cells, we found that: (a) TCR/CD3-medi-
ated signals were sufficient to induce low levels of CD4,
but that CD4 induction was markedly enhanced by CD28
costimulation (Fig. 3 D), and (b) cellular proliferation was
neither sufficient or necessary. Indeed, CD4 was not ex-
pressed on proliferating CD81 T cells stimulated with anti-
CD2 together with anti-CD28 mAbs and IL-2, whereas it
was induced on irradiated (nonproliferating) anti-CD3/
B7.1–stimulated cells (data not shown). Finally and impor-
tantly, CD4 was coexpressed on neonatal T cells activated
under more physiological conditions, i.e., by antigenic
stimulation with allogeneic dendritic cells (Fig. 3 D). Thus,
physiological activation of umbilical cord blood CD81 T
cells is associated with the coexpression of low to moderate
levels of CD4, most likely as a result of CD4 gene tran-
scriptional activation. Moreover, effective costimulation is
required for optimal induction of CD4 coexpression, pre-
sumably explaining why this phenomenon went unnoticed
in earlier studies. Consistent with their susceptibility to in-
fection with M-tropic HIV, activated neonatal T cells ex-
pressed CCR5 mRNA (Fig. 3 B). Interestingly, they also
expressed CXCR4/fusin protein and mRNA (Fig. 3 E). As
already mentioned, it is suggested that their resistance to
T-tropic HIV infection results from a postentry block in
viral replication (17–20). The ability to coexpress CD4 is
not a unique feature of neonatal CD81 T cells, and indeed
a variable proportion (10–40%, n 5 5) of CD81 T cells iso-
lated from adult blood expressed low levels of CD4 after
anti-CD3/B7.1 activation (data not shown). Since neonatal
CD81 T cells are immunologically naive whereas their
adult counterparts contain both naive and memory cells, it
will be of interest to examine CD4 expression and suscepti-
bility to HIV infection in naive and memory CD81 T cell
Figure 1. Infection of neonatal CD41 and CD81 cells. Umbilical cord
blood CD41 and CD81 T cells were activated with anti-CD3 and B7-
1–transfected CD32 L cells for 3 d, washed, expanded in IL-2, and in-
fected with either a CCR5-dependent virus, HIVUS1, or a CXCR4-depen-
dent virus, HIV-1NL4-3. The PhosphorImage shows the accumulation of
gag DNA in CD4 and CD8 cultures at 0, 2, 72, and 144 h after infection.
To ensure equivalent amounts of DNA were in the PCR reaction, hu-
man b-globulin sequences were amplified.
Figure 2. Intracellular HIV-1 staining of neonatal CD81 cells. Neona-
tal CD81 T cells were harvested 6 d after infection and stained with both
anti-CD8 and labeled HIV DNA probes. Left, FACSÒ analysis of cells in-
fected with HIVUS1; right, a mock-infected control.1142 HIV Infection of CD81 T Cells
subsets. Preliminary results suggest that indeed, naive but
not memory adult CD81 T cells may be induced to coex-
press CD4 and become infectable by HIV.
These observations have potentially important biological
and clinical implications. They challenge the paradigm that
the CD4 gene is irreversibly silenced in extrathymic mature
single positive CD8-a/b TCR-a/b T lymphocytes and
raise the question of the role of CD4 in the biology of
CD81 T cells. A small fraction (2–3%) of peripheral TCR-
a/b T cells are CD8 CD4 double positive (22). In the
large majority of the cases, these cells are CD4bright CD8dull
and express CD8 as a CD8-a/a homodimer (23). In three
cases however, the double positive T cells were shown to
display the same phenotype as activated neonatal CD81 T
cells, i.e., CD8-a/bbright CD4dull, indicating that cells ex-
pressing this phenotype exist in vivo (24). Finally, infection
of CD81 T cells by human herpesvirus 6 was previously
shown to induce CD4 expression and confer susceptibility
to HIV infection (25). From a clinical point of view, our
finding may explain the recent reports that CD81 T cells of
infected patients can harbor HIV-1 (26, 27). It is tempting
to relate the HIV susceptibility of neonatal CD81 T cells to
the rapid progression of the disease in a large proportion of
infected neonates. Since viral replication is mainly con-
trolled by CD81 T cells, it seems reasonable to assume that
the infection of these cells may compromise the immune
response to HIV. Productive infection of primary HIV-
specific CD81 T cells may lead to an early disruption of the
Ag repertoire of HIV-specific CD81 T cells. Infected
CD81 T cells may be deleted directly, after supporting
high rates of viral replication, or indirectly by cytotoxic
HIV-specific CD81 T cells. Early restriction of the antigen
Figure 3. Expression of CD4, CXCR4, and CCR5 on neonatal CD81 T cells. Umbilical cord blood CD81 T cells were activated with anti-CD3
mAb immobilized on B7.1 and CD32–transfected L cells and expanded in IL-2–supplemented medium. (A) Two-dimensional contour plot showing ex-
pression of CD4 and CD8 before T cell activation, after 24 and 72 h of primary activation, and at the end of a second cycle of activation/IL-2 expansion
(day 14). Similar results were obtained by staining with OKT4 mAb, recognizing another CD4 epitope than Leu3a mAb. More than 95% of resting or
activated CD81 T cells were stained brightly with 2ST8 mAb (received from E. Reinherz, Harvard Medical School, Boston, MA) specific for the CD8-
a/b heterodimer. (B) Expression of CD4, CXCR4, and CCR5 mRNA in resting and activated (day 7) neonatal CD41 and CD81 T cells. (C) Compar-
ison of CD4 expression on activated CD41 and CD81 T cells. Cells were stained with anti-CD4 mAb at the end of the first cycle of activation/IL-2
expansion (day 7). (D) CD4 expression on CD81 T cells activated with either plate-coated anti-CD3 (10 mg/ml), immobilized anti-CD3 together with
soluble anti-CD28 (clone 9.3, 500 ng/ml), anti-CD3 (200 ng/ml) immobilized on B7.1 CD32 L cells, or allogeneic dendritic cells together with IL-2 (50
IU/ml). Cells were stained at day 7 with anti-CD4 and anti-CD8 mAbs. (E) CXCR4 expression on activated CD81 T cells. Anti-CD3/B7.1–activated
CD81 T cells were stained with 12G5 mAb at day 7.1143 Yang et al. Brief Definitive Report
repertoire would facilitate the emergence of HIV variants
expressing functionally important Ags that were recognized
by the deleted T cells (28–30). Future studies aiming to
verify in vivo some of these hypotheses and to confirm the
differential susceptibility of naive versus memory CD81 T
cells to HIV infection should further our understanding of
the disease and have important implications for the devel-
opment of HIV vaccines.
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